In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Thoratec Laboratories acquires Thermo Cardiosystems

Executive Summary

Thoratec Laboratories (circulatory support and vascular graft application devices) has acquired Thermo Electron's Thermo Cardiosystems (implantable left ventricular-assist systems (LVAS)) in a $695mm tax-free stock swap. Thermo Cardiosystems shareholders will receive 0.835 of a newly issued Thoratec share (valued at $18.02, a (pr)95% premium based on the market average) for each share they own. Thoratec will also assume $45mm in debt.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Includes Contract
    • Payment Includes Stock

Related Companies